Compare Else Nutrition Holdings, Inc. with Similar Stocks
Dashboard
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate 9.00% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -15.34
2
Risky -
3
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
CAD 1 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.43
172.55%
-0.29
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Mar 2026)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-61.54%
0%
-61.54%
6 Months
-80.0%
0%
-80.0%
1 Year
-87.5%
0%
-87.5%
2 Years
-98.86%
0%
-98.86%
3 Years
-99.63%
0%
-99.63%
4 Years
-99.79%
0%
-99.79%
5 Years
0%
0%
0.0%
Else Nutrition Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.45%
EBIT Growth (5y)
9.00%
EBIT to Interest (avg)
-15.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.27
Sales to Capital Employed (avg)
1.17
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.29
EV to EBIT
-0.56
EV to EBITDA
-0.58
EV to Capital Employed
-1.28
EV to Sales
0.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Bearish
OBV
No Trend
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
1.50
2.10
-28.57%
Operating Profit (PBDIT) excl Other Income
-0.60
-1.60
62.50%
Interest
0.10
0.10
Exceptional Items
-0.10
-2.30
95.65%
Consolidate Net Profit
-0.60
-3.40
82.35%
Operating Profit Margin (Excl OI)
-419.80%
-802.40%
38.26%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -28.57% vs 0.00% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 82.35% vs 38.18% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
6.00
8.00
-25.00%
Operating Profit (PBDIT) excl Other Income
-6.10
-14.40
57.64%
Interest
1.30
0.10
1,200.00%
Exceptional Items
-1.00
-0.60
-66.67%
Consolidate Net Profit
-8.90
-15.20
41.45%
Operating Profit Margin (Excl OI)
-1,052.00%
-1,845.90%
79.39%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -25.00% vs -14.89% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 41.45% vs 2.56% in Dec 2024
About Else Nutrition Holdings, Inc. 
Else Nutrition Holdings, Inc.
Pharmaceuticals & Biotechnology
Else Nutrition Holdings Inc., formerly ASB Capital Inc., is a Canada-based company. The Company is the developer of food products and formula nutrition for infants and toddlers.
Company Coordinates 
Company Details
Fairmont Pacific Rim , VANCOUVER BC : V6C 0B2
Registrar Details






